Rykin_Capital

Shorting Lyell Immunopharma. LYEL

Короткая
Rykin_Capital Обновлено   
NASDAQ:LYEL   Lyell Immunopharma, Inc.
Believing B/C pivot just happened and we are moving down. Since we recover to ~ 0.618 of A we may reach new lows in this run downwards.

We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
Сделка закрыта: достигнута тейк-профит цена:
First two by 7th OCT

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.